TradingView
timwest
Feb 27, 2015 9:27 PM

Bristol-Myers Squibb - 10% downside potential  Short

Bristol-Myers Squibb CompanyNYSE

Description

When I see a stock go from 2.6 times sales to 6.4 times sales while revenues have fallen from $21 billion to $16 billion, you can tell that investors are hoping for something big coming down the road.

For now, I'll look for a trip down to the lower end of the rising regression channel.

Risk - $64 or $65. Target $53-$54.

Tim 4:25PM EST Feb 27, 2015
Comments
A-shot
I bet it gets down with the looming market correction
IvanLabrie
This is really great Tim...Definitely a great opportunity.
timwest
BMY keeps chugging along in the uptrend channel, defying gravity and the logic of valuation. Buyers must know something we don't or else watch out below. 67.55 last, July 6, 2015. 3:31PM EST
More